Alternatives
Alternatives to Avtozma 162 mg/0.9 mL injection
There are 4 alternatives to this medicine in the catalogue: the same active ingredient (Tocilizumab), strength (162 mg/0.9 mL) and dosage form (injection) from 2 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Avtozma 162 mg/0.9 mL injectionThis pageSubcutaneous | Celltrion | US FDA | 1 syringe of 0.9 mL, 4 syringes of 0.9 mL | Cold chain | On request | — | Available on request |
| Tyenne 162 mg/0.9 mL injectionSubcutaneous | Fresenius Kabi | US FDA | 1 syringe of 0.9 mL, 1 syringe of 0.9 mL | Cold chain | On request | — | Available on request |
| Tyenne 162 mg/0.9 mL injectionSubcutaneous | Fresenius Kabi | US FDA | 1 syringe of 0.9 mL, 1 syringe of 0.9 mL | Cold chain | On request | — | Available on request |
| Actemra 162 mg/0.9 mL injectionSubcutaneous | Genentech | US FDA | 1 syringe of 0.9 mL | Cold chain | On request | — | Available on request |
| Actemra ACTPen 162 mg/0.9 mL injectionSubcutaneous | Genentech | US FDA | 1 syringe of 0.9 mL | Cold chain | On request | — | Available on request |
This is a biological medicine. Products from other makers are biosimilars, not identical copies, and switching between them follows the prescriber's and regulator's rules.
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Avtozma 162 mg/0.9 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.